Lisa Rebuzzi

Dr. Lisa Rebuzzi


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
CZCaterina Zoratti
Caterina Zoratti
RMRita Moretti
Rita Moretti
LRLisa Rebuzzi
Lisa Rebuzzi
IAIrma Valeroa Albergati
Irma Valeroa Albergati
ASAntonietta Di Somma
Antonietta Di Somma
Mauro GiuffrèMauro Giuffrè
Mauro Giuffrè
The liver is the primary site of drug metabolism, which can be altered by a variety of diseases affecting the liver parenchyma, especially in patients with liver cirrhosis. The use of antibiotics in patients with cirrhosis is usually a matter of concern for physicians, given the lack of practical knowledge for drug choice and eventual dose adjustments in several clinical scenarios. The aim of the current narrative review is to report, as broadly as possible, basic, and practical knowledge that any physician should have when approaching a patient with liver cirrhosis and an ongoing infection to efficiently choose the best antibiotic therapy.